Researchers at the Indian Institute of Technology Madras (IIT-M) have developed a novel, non-invasive device to assess the health and age of blood vessels and thereby provide early screening for cardiovascular diseases.
Called ARTSENS, it is designed such that it can be used in routine medical examination by even non-experts, to assess and predict vascular health.
It is powered by a proprietary non-imaging probe and an intelligent computing platform and is developed by the Healthcare Technology Innovation Centre at IIT-M, said a press release from the institute.

ARTSENS, the image-free ultrasound device to assess the health and age of blood vessels developed by IIT Madras Researchers
ARTSENS has been approved for clinical studies in India, US, and Europe. The device has been assessed on more than 5,000 human subjects. The IIT-M team intends to deploy this to conduct over a million vascular screenings per year.
The product is ready for technology transfer and commercialisation after extensive testing. The technology already has five utility patents in the US, European Union, and India, 10 design patents, and awaits awarding of 28 patents in various jurisdictions.
Watch
How ARTSENS works
Scientists at Radboud University Medical Center, the Netherlands, are using this device to investigate the association between arterial age, physical (in)activity, and cardiovascular events and AIIMS New Delhi researchers are using it to study and understand the physiological underpinnings of arterial ageing in various disease conditions, the release added.

Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.